<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03587623</url>
  </required_header>
  <id_info>
    <org_study_id>Livercopeptin</org_study_id>
    <nct_id>NCT03587623</nct_id>
  </id_info>
  <brief_title>Copeptin Serum Level in Liver Transplant Recipients</brief_title>
  <official_title>Copeptin Serum Level in Liver Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <brief_summary>
    <textblock>
      The study aim is to measure perioperative copeptin concentration in blood of liver transplant
      recipients and to assess whether there is a correlation between its level and hemodynamic
      derangement.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 4, 2018</start_date>
  <completion_date type="Anticipated">September 4, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 4, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Copeptin concentration</measure>
    <time_frame>Baseline, intraoperatively, 1,3,7,21 day postoperatively</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Copeptin</condition>
  <condition>Liver Transplant</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing liver transplant
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patient undergoing liver transplantation

        Exclusion Criteria:

          -  Serum creatinine &gt; 1,5 mg/dl

          -  Retransplantation

          -  Patient refusal

          -  CRRT or dialysis preoperatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>I Klinika Anestezjologii WUM</name>
      <address>
        <city>Warsaw</city>
        <state>Mazovian Voivodeship</state>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beata Błaszczyk, MD, PhD</last_name>
      <phone>004822502121</phone>
      <email>klinanest1@wum.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Piotr Mieszczański, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>July 3, 2018</study_first_submitted>
  <study_first_submitted_qc>July 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2018</study_first_posted>
  <last_update_submitted>October 9, 2018</last_update_submitted>
  <last_update_submitted_qc>October 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Beata Błaszczyk</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Diabetes Insipidus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

